Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in FLGT — Fulgent Genetics, Inc.

CIK 1423053 MIAMI, FL
Back to FLGT Full portfolio

Position in FLGT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$841,873
-$5,544,993 QoQ
Shares Held
52,948
-78.2% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Derivatives in FLGT

reported options exposure · as of Mar 31, 2026
CallValue
$190,800
CallShares
12,000
PutValue
$162,180
PutShares
10,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,657,068,556 across 34 Diagnostics & Research names. FLGT ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 864,489 $424,922,277
2 CRL
Charles River Laboratories International, Inc.
 1,212,152 $209,096,220
3 A
Agilent Technologies, Inc.
 1,801,714 $205,359,361
4 DHR
Danaher Corp /De/
 1,026,347 $194,595,390
5 MTD
Mettler Toledo International Inc/
 58,054 $73,217,704
6 GH
Guardant Health, Inc.
 775,941 $71,673,669
7 DGX
Quest Diagnostics Inc
 347,218 $68,047,783
8 IQV
Iqvia Holdings Inc.
 390,042 $66,517,762

All Filings in FLGT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $841,873 52,948
2026-03-31 $162,180 10,200
2026-03-31 $190,800 12,000
2025-12-31 $475,487 18,100
2025-12-31 $6,386,866 243,124
2025-09-30 $1,823,820 80,700
2025-09-30 $8,395,357 371,476
2025-06-30 $12,000,621 603,653
2025-06-30 $2,449,216 123,200
2025-06-30 $493,024 24,800
2025-03-31 $926,120 54,800
2025-03-31 $7,364,039 435,742
2025-03-31 $659,100 39,000
2024-12-31 $716,636 38,800
2024-12-31 $598,428 32,400
2024-12-31 $4,185,652 226,619
2024-09-30 $245,549 11,300
2024-09-30 $6,582,407 302,918
2024-09-30 $623,651 28,700
2024-06-30 $559,170 28,500
2024-06-30 $156,960 8,000
2024-06-30 $3,653,929 186,235
2024-03-31 $2,439,926 112,439
2024-03-31 $618,450 28,500
2024-03-31 $1,751,190 80,700
2023-12-31 $3,552,460 122,880
2023-12-31 $4,634,273 160,300
2023-12-31 $2,194,269 75,900
2023-09-30 $5,161,247 193,016
2023-09-30 $5,420,198 202,700
2023-09-30 $2,676,674 100,100
2023-06-30 $17,197,546 464,422
2023-06-30 $2,436,574 65,800
2023-06-30 $2,451,386 66,200
2023-03-31 $9,309,023 298,175
2023-03-31 $2,182,278 69,900
2023-03-31 $2,163,546 69,300
2022-12-31 $2,159,050 72,500
2022-12-31 $2,045,886 68,700
2022-12-31 $1,707,168 57,326
2022-09-30 $5,100,456 133,800
2022-09-30 $6,281,908 164,793
2022-09-30 $2,077,540 54,500
2022-06-30 $3,010,056 55,200
2022-06-30 $6,692,793 122,736
2022-06-30 $9,657,263 177,100
2022-03-31 $3,823,735 61,268
2022-03-31 $6,734,039 107,900
2022-03-31 $10,328,855 165,500
2021-12-31 $5,763,807 57,300

Report a Problem

Category
Description
Email (optional, for follow-up)